Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma

Update Il y a 4 ans
Reference: NCT01813136

Woman and Man

  • | Country :
  • France
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The objective of this study is to determine the feasibility of pazopanib treatment interruption with reintroduction at progression in iodine refractory progressive Differentiated Thyroid Cancer (DTC) patients as compared to pazopanib continuous administration.


Inclusion criteria

  • Thyroid carcinoma

Links